Tag: Pphn

Inhaled nitric oxide (iNO) improves oxygenation and reduces the need for ECMO in term infants with hypoxic respiratory failure [1.8.5]. A critical phase of this therapy is learning how to wean iNO safely to prevent complications like rebound pulmonary hypertension.

Persistent pulmonary hypertension of the newborn (PPHN) is a life-threatening neonatal condition that affects approximately 1.9 out of every 1,000 live births in the United States. For infants with this condition, understanding **what is the mechanism of action of sildenafil in PPHN** is crucial, as the drug can selectively relax blood vessels in the lungs and improve oxygenation.

Persistent pulmonary hypertension of the newborn (PPHN), a primary indication for iNO therapy, occurs in approximately 1.9 per 1,000 live births [1.9.2]. So, what is iNO in nursing? It is a critical intervention involving the administration of inhaled nitric oxide, a selective pulmonary vasodilator, to improve oxygenation.

Persistent pulmonary hypertension of the newborn (PPHN) affects approximately 1.9 per 1,000 live births in the United States [1.5.6]. A primary treatment for this condition is Inhaled Nitric Oxide (iNO). So, **what is INO used for?** It is a selective pulmonary vasodilator used to improve oxygenation in newborns with hypoxic respiratory failure [1.6.4, 1.4.2].